Medicines and Healthcare products Regulatory Agency

“We have considered your request as one to cover ventilators as a whole rather, than limited to models which only provide a CPAP function. To provide a full response to this request, we contacted Philips Respironics on 10 August 2021 and asked them to investigate, provide clarification on the reported problem and report their findings back to us. We also asked for a summary of the alarms on the Trilogy 202 for all alarm scenarios, how each one sounds, and what message is displayed when they are”

“The MHRA will review the packaging of these medicines and if we consider on assessment that improvements could be made we will contact any pharmaceutical manufacturers who supply these medicines and seek changes so that the likelihood of future errors of this nature may be reduced.”

“We are satisfied that WMAS took proactive and suitable actions following the death of Mrs [name redacted] to reduce the risk of a similar incident occurring and no enforcement action was taken against the trust.”

“We have taken note of your suggestion that the”

“Following Ms [name redacted] death, the Practice undertook an audit in October 2019 of all patients who were being prescribed Emerade to ensure that the dosage was in accordance with the BNF based on the respective patients' weight and age. Indeed, all patients who use AAI pens have had their doses reviewed. Patients have been contacted to ensure that they have the correct dose and appropriate knowledge about the use and storage of the pen. Letters were sent to patients on Emerade, which included”

“we will consider how best to make clear In CG134 the advice that 2 adrenaline auto-injectors should be prescribed, which patients should carry at 811 tfflls.”

“Introducing library conditions within the dispensary. Commencing with immediate effect.”

“the exit route (after 5pm) from the 31st January department which is currently located next to the 2020 accuracy checking area. Staff will exit the department via the pharmacy reception exit, preventing staff using the dispensary as a thoroughfare”

“Reviewing the layout of the dispensary with the aim 29th February of separating the areas used for different parts of 2020 the dispensing process and improving the flow of work.”

“closed loop dispensing" (linking the 30th June 2020 electronic prescribing system to the pharmacy dispensing system and robot) with the aim of reducing dispensing errors and improving efficiency and therefore reducing the number of staff needed in the dispensary”

“Updating the accuracy checking procedure which 31st December will incorporate a second check for all intravenous 2019 fluids.”

“manufacturers were required to disclose the exposed needle length of their adrenaline auto-injector devices in the product information to inform the healthcare professional and patient so they can take this in to account in deciding which device is appropriate for an individual patient”

“Consider more prominent labels and alerts re fire hazard on product containers”

“We aim to have completed our review by the end of 2017 and will consider the need for publication of any additional safety advice at this time in conjunction with our medicine colleagues.”

“PAGB and its member companies recognise that clear information needs to be made available to warn of the risk of increased flammability of clothing and bedding which has been in contact with paraffin-containing emollients.”

“We will also publish an article in the MHRA's Drug Safety Update Bulletin to alert healthcare professionals to the risks.”

“I shall liaise with the Chair of our Special Committee for Psychopharmacology to publicize these matters to the members and fellows of the RCPsych”

“I shall liaise with the Chair of the Faculty of Old-Age Psychiatry to determine the best way to raise these issues with old-age psychiatrists”

“We will review our continuing medical education initiatives to ensure that this issue is comprehensively covered in RCPsych material”

“I shall inform the Presidents of the Royal Colleges of Physicians and General Practitioners, by copy of this letter, of our plans and will be ready to work with them in any suitable joint ventures”

“We have reviewed the product information (Summary of Product Characteristics [SmPC] and Patient Information Leaflet) of olanzapine, mirtazapine and indapamide and are satisfied that all three contain appropriate warnings regarding the risk of QT prolongation, particularly when used with other medication that also causes QT prolongation.”